Biogen Pharmachem Current Share Price | Biogen Pharmachem Stock Screener
BIOGEN
Other Financial Services
Biogen Pharmachem Current Stock Price Today
Live Share Price BSE
₹0.27
▼
-0.01 (-3.57%)
As of September 18, 2026, the live Biogen Pharmachem share price (BSE: BIOGEN) is ₹0.27, down 3.57% from the previous close, with shares trading between ₹0.26 and ₹0.28 in today's trading session, and a 52-week range of ₹0.26–₹0.90.
Browse BIOGEN complete financial statements to support your investment research.
Use the Biogen Pharmachem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Biogen Pharmachem Market Cap
₹28.40 Cr.
BIOGEN P/E Ratio (TTM)
-
Biogen Pharmachem P/B Ratio
0.29
EPS (TTM)
₹0.01
Dividend Yield
-
Debt to Equity
-
BIOGEN 52 Week High
₹0.90
Biogen Pharmachem 52 Week Low
₹0.26
Operating Margin
-
Profit Margin
-
BIOGEN Revenue (TTM)
₹1.00
EBITDA
-
Net Income
-
Total Assets
₹99.00
Total Equity
₹99.00
Biogen Pharmachem Current Share Price Chart
Track the current Biogen Pharmachem share price and stock price with an interactive chart. Analyse BIOGEN price trends, trading volume, historical performance, and volatility across different timeframes — the complete Biogen Pharmachem stock quote in one place.
Biogen Pharmachem Company Profile - Fundamental Screener
Screen Biogen Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BIOGEN shares.
Sector
Financial Services
Industry
Other Financial Services
Sub-Sector
Other Financial Services
Segment
E
ISIN
INE703D01023
Biogen Pharmachem Balance Sheet Screener
Screen BIOGEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 99 | 92 | 57 | 55 | 55 | 54 | 56 | 58 | 56 | 63 |
| Current Assets | 1 | 3 | 0 | 0 | 2 | 3 | 8 | 8 | 7 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 99 | 92 | 57 | 55 | 54 | 54 | 56 | 54 | 54 | 61 |
| Share Capital | 90 | 65 | 65 | 65 | 65 | 65 | 65 | 65 | 65 | 65 |
| Reserves & Surplus | 9 | -9 | -9 | -11 | -11 | -11 | -10 | -11 | -11 | -4 |
Biogen Pharmachem Income Statement Screener - Profit & Revenue Analysis
Screen Biogen Pharmachem income statement and profit fundamentals.
Analyze BIOGEN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Biogen Pharmachem share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 3 | 1 | 2 | 1 | 3 | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 2 | 2 | 2 | 1 | 1 | 3 | 3 | 0 | 1 | 7 | 0 | 0 | 0 |
| EBITDA | 0 | 1 | 0 | 2 | 1 | 0 | -2 | 0 | 0 | -7 | 0 | 0 | 0 |
| Operating Profit % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1.00% | -99.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 0 | 2 | 1 | 0 | -2 | 0 | 0 | -7 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 0 | 2 | 1 | 0 | -2 | 0 | 0 | -7 | 0 | 0 | 0 |
| EPS | 0.00 | 0.01 | 0.00 | 0.03 | 0.01 | 0.00 | -0.02 | 0.00 | 0.00 | -0.10 | 0.00 | 0.00 | 0.00 |
Biogen Pharmachem Cash Flow Screener - Liquidity Fundamentals
Screen BIOGEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 2 | -1 | 2 | 2 | 1 | 4 | -1 | 0 | -14 | 0 |
| Investing Activities | -10 | -33 | -2 | -2 | -1 | -4 | 2 | -1 | 14 | 4 |
| Financing Activities | 6 | 36 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | -4 |
| Net Cash Flow | -2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Biogen Pharmachem Shareholding Pattern Screener
See Biogen Pharmachem shareholding pattern with promoter, FII, and DII holdings.
Check Biogen Pharmachem promoter holding and ownership changes for BIOGEN on TickJournal.
| Item | 2026-Mar | 2026-May | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 56.92% | 69.24% | 71.08% | 76.46% | 55.33% | 55.38% | 55.43% | 76.85% |
| Other Holding | 43.07% | 30.76% | 28.92% | 23.54% | 44.67% | 44.62% | 44.56% | 23.15% |
| Shareholder Count | 289,155 | 293,831 | 293,626 | 302,362 | 303,922 | 293,327 | 289,987 | 197,757 |
Biogen Pharmachem Share Dividend Screener - Share Yield Analysis
Check Biogen Pharmachem dividend history with payout and yield data.
View Biogen Pharmachem dividend details including ex-dates and amounts for BIOGEN stock.
Biogen Pharmachem Stock Index Membership
See which indices include Biogen Pharmachem stock.
Check BIOGEN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Biogen Pharmachem Market Events Screener - Corporate Actions
Get Biogen Pharmachem corporate actions including splits, bonuses, and buybacks.
Check Biogen Pharmachem stock events that may affect BIOGEN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -3.57% |
| 2026-08-05 | 2026-08-05 | Quarterly Result Announcement | NA | -9.38% |
| 2026-05-15 | 2026-05-15 | Bonus | 1:6 | -18.60% |
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | -7.50% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 1.75% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -2.82% |
| 2025-09-25 | 2025-09-25 | Annual General Meeting | NA | -3.85% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | -1.23% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 22.54% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -2.73% |
| 2024-09-28 | 2024-09-28 | Annual General Meeting | NA | 0.90% |
| 2024-02-01 | 2024-02-01 | Extraordinary General Meeting | NA | -10.00% |
| 2021-01-22 | 2021-01-22 | Change Of Name | NA | 0.00% |
Biogen Pharmachem Competitors Screener - Peer Comparison
Screen BIOGEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| OnEMI Technology Solutions | 5,538 | 18.65 | 2,209 | 63.31% | 282 | 59.83 |
| Spice Lounge Food Works | 2,296 | 142.64 | 158 | 48.89% | 9 | 68.59 |
| Algoquant Fintech | 1,816 | 39.52 | 235 | 0.32% | 30 | 49.52 |
| Gyftr | 1,350 | 66.16 | 380 | 2540.69% | 22 | 53.12 |
| Prime Securities | 961 | 201.34 | 137 | 52.92% | -2 | 50.59 |
| Wealth First Portfolio Managers | 901 | 27.17 | 68 | 13.79% | 38 | 39.09 |
| RNFI Services | 851 | 27.09 | 969 | 4.89% | 31 | 74.66 |
| Stellant Securities | 559 | 37.43 | 0 | % | 0 | 54.83 |
| Kalind | 528 | 13.40 | 80 | 15870.00% | 27 | 46.05 |
| Investment Trust of India | 506 | 14.00 | 302 | -17.34% | 35 | 49.73 |
Biogen Pharmachem Company Announcements - News Screener
Screen BIOGEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-09 | Reg. 34 (1) Annual Report. | - |
| 2026-09-09 | Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-09-09 | Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-05 | Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-05 | Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | - |
| 2026-08-05 | Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th August 2026. | - |
| 2026-07-21 | Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting. | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-12 | Closure of Trading Window | - |
| 2026-05-23 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-20 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-20 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-20 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-19 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-18 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-05-14 | Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-14 | Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | - |
| 2026-05-14 | Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2026 And Outcome Of The Board Meeting Held On Thursday 14Th May 2026. | - |
| 2026-05-04 | Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting. | - |
| 2026-04-27 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |